Challenges with epilepsy diagnosis and monitoring
- Patient reporting and seizure diaries are inaccurate
- Uncertainty of treatment effect due to infrequent visits
- Access to EMU can be restricted – long waiting lists
- No seizures or atypical seizures during EMU stay
- There can be a lack of personnel to review all VEEG data
- Events can be missed, even by most experienced people
- EMU can be located far from patient’s home
- Patients don’t always like prolonged stay at EMU
Nelli® uses an easy workflow and platform.
The combination of AI and human
expertise, without EEG, is revolutionary.
When is Nelli® used?
Prescreening
An easy way to optimise the flow to the EMU, potentially eliminating the need for admission or allowing for better information when the patient gets admitted
Diagnosis
Helping with differential diagnosis, classification, quantification of seizure types and complex case analysis – all based on objective information.
Treatment effect
Effective way to assess effect of treatment and treatment changes at home. Complements seizure diaries which are inaccurate.
Nelli® provides value
-
Faster, better diagnosis and follow-up
Better understanding the type and number of events helps the physician prescribe the right treatment – Monitoring at home helps assessing whether it works and make the necessary changes which leads to better outcomes.
-
Safer
Reducing the need to provoke seizures on the EMU, eliminates the risks associated with it. Understanding if a treatment alleviates or increases seizures, allows for quicker corrective action if needed and can eliminate side-effects and risk associated.
-
Reduced burden for the patient
Patient can be diagnosed and monitored at home which is more comfortable and reduces need for travel. Patients and caregivers don’t need to worry about counting seizures at night.
-
Cost-effective
Use of Nelli® at home can reduce the need for prolonged, expensive hospital stays. A better remote understanding of the treatment effect eliminates the need for frequent consultations.